Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-002160
Filing Date
2021-02-22
Accepted
2021-02-22 16:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27635
2 filename2.txt TEXT-EXTRACT 1404
  Complete submission text file 0000000000-21-002160.txt   40360
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filed for) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 7389 Services-Business Services, NEC